BioScience Trends
Online ISSN : 1881-7823
Print ISSN : 1881-7815
Reviews
Direct-acting agents for hepatitis C virus before and after liver transplantation
Yasuhiko SugawaraTaizo Hibi
Author information
JOURNALS FREE ACCESS

2017 Volume 11 Issue 6 Pages 606-611

Details
Abstract

Chronic hepatitis C virus (HCV) infection remains a widespread public health concern and many people are infected with HCV. HCV is one of the leading indications for liver transplantation. Direct-acting antiviral agents (DAAs) against HCV have changed the course of chronic HCV infection, however, making it a curable disease. DAA treatment may be initiated before or after liver transplantation. In the present review, we present the available data on DAA treatment of HCV in liver transplant recipients.

Information related to the author
© 2017 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Next article
feedback
Top